Introduction
Traditional Chinese Medicines (TCMs) have been used in clinical practice for a long history, and their therapeutic effects are generally considered credible. However, to find out the active ingredients that play a therapeutic role is not easy due to their complicated chemical composition. One feasible way is to identify the in vivo metabolites because only the exposed chemicals could play the role, in most cases. Moreover, to clarify "what are absorbed" (chemical constituents of the TCM per se) and "what are produced" (biotransformed metabolites) is the basis for pharmacokinetic studies. Unfortunately, the metabolism of TCMs is a complicated "system to system" process, and has been a great challenge (Lan and Jia, 2010) . TCMs contain multiple compounds which vary significantly in structural types, physiochemical properties, and relative amounts. When they are used in the traditional manner, i.e. water decoction administered by oral route, a number of compounds may get into circulation and then be converted into even more metabolites.
Identification of these absorbed constituents and their metabolites are usually hindered by their fairly low concentrations in vivo and poor understanding in the metabolic pathway.
Given the above-mentioned difficulties in TCM metabolic studies, most current reports focused on only one or a few single compounds, which could not represent the whole herbal medicine (Qiu, 2010) . Some other reports used very high dosage of concentrated herbal extracts (40 to 200 times higher than clinical dosage) to make sure the metabolites could be detected in bio-samples (Wang et al., 2007; Tan et al., 2010) . clinical therapy. Furthermore, only a few metabolites were characterized in most reports even when highly sensitive technologies like LC/MS were used. In order to systematically characterize the metabolites of TCMs at an oral clinical dosage, a new strategy is needed.
In the present work, we propose a strategy to systematically characterize the in vivo metabolites of TCMs at an oral clinical dosage. An illustrative diagram is shown in Scheme 1. The strategy consisted of three steps, (i) characterize the metabolites of representative single compounds of a TCM by LC/MS, and then analyze the metabolic pathways of each type of compounds; (ii) administer a high dosage of herbal extracts and discover more metabolites according to metabolic pathways of the same type of compounds; (iii) establish a highly sensitive and selective LC/SRM-MS method, and detect all the metabolites in bio-samples at a normal clinical dosage. This strategy was realized by using licorice as a model herb.
Licorice was selected as the model herb because it is the most frequently used TCM. It appears in about 60% of all TCM prescriptions (Wang and Yang, 2007) . Licorice is derived from the roots and rhizomes of Glycyrrhiza uralensis, G. inflata, and G. glabra (Chinese Pharmacopoeia Commission, 2010) , and is mainly used to treat peptic ulcer, cough, and hepatitis C (Asl and Hosseinzadeh, 2008) . Up to date, more than 400 compounds have been isolated from licorice, and the major constituents are flavonoids and saponins (Zhang and Ye, 2009 ). The metabolism of licorice has been extensively studied. Most of these studies were focused on single licorice compounds like glycyrrhizic acid (Makino et al., 2008) , This article has not been copyedited and formatted. The final version may differ from this version. (Shimamura et al., 1993) , and isoliquiritigenin (Guo et al., 2008a (Guo et al., , 2008b Cuendet et al., 2010) . Some other studies attempted to detect the in vivo metabolites after licorice extracts were administered (Homme et al., 1997; Zuo et al., 2003; Hou et al., 2005) .
However, only a few compounds were detected in most reports. Recently, 25 licorice compounds were detected in rat plasma after a high dosage of ethanol extract (40 g/kg) was administered, while no biotransformed metabolites were characterized (Tan et al., 2010) . To the best of our knowledge, no report is available to provide a full metabolic profile of licorice at a normal dosage.
In this paper, the in vivo metabolites of licorice water extract (LWE) in rats at a normal clinical dosage were systematically characterized by our new strategy. Firstly, the metabolism of ten representative single compounds was studied, and a total of 68 metabolites were characterized. Secondly, a high dosage (20-fold clinical dosage) of LWE was administered, and 22 more metabolites were characterized. Finally, a normal clinical dosage of LWE was administered to rats, and 42 metabolites were detected in plasma and 62 in urine by a highly sensitive LC/SRM-MS method.
This article has not been copyedited and formatted. The final version may differ from this version. 
Materials and Methods

Chemicals and reagents
Licorice (the dried roots and rhizomes of Glycyrrhiza uralensis Fisch.) was purchased from Elion Resources Group Company (Inner Mongolia, China), and was authenticated by comparing its HPLC fingerprint with that of a reference sample from China National Institutes for Food and Drug Control (Beijing, China). Liquiritigenin (LG), liquiritin (LQ), liquiritin apioside (LA), isoliquiritigenin (ILG), isoliquiritin (ILQ), isoliquiritin apioside (ILA), ononin (ONO), glycyrrhizic acid (GLY), 7,4′-dihydroxyflavone (DHF), isoangustone A (IAA), formononetin (FOR), glycyrrhetinic acid, genkwanin, licoisoflavone A, licoisoflavone B, semilicoisoflavone B, and glycycoumarin were isolated from licorice by the authors. The structures were fully characterized by NMR spectroscopy and mass spectrometry. The purities were above 98% determined by HPLC/UV analysis. Daidzein, naringenin, and naringenin dihydrochalcone were purchased from Zelang Co. Ltd.
(Nanjing, China). S-equol, together with β -glucuronidase (HP-1 type, prepared from Helixa pomatia having a β -glucuronidase activity of 1,926,000 U/g and a sulfatase activity of over 10,000 U/g) were purchased from Sigma-Aldrich (St. Louis, MO). HPLC-grade acetonitrile was from J.T. Baker (Philipsburg, NJ, USA). Ultra-pure water was prepared with a Milli-Q water purification system (Millipore, Bedford, MA, USA). All other reagents were of analytical grade.
Synthesis of davidigenin
Davidigenin (DA) was synthesized by hydrogenation of isoliquiritigenin (ILG)
This article has not been copyedited and formatted. The final version may differ from this version. , 1997) . Fifty milligrams of ILG was dissolved in 10 mL of ethanol and hydrogenated over palladium-charcoal (0.1 g) under vigorous stirring at room temperature for 2 h. After filtration and evaporation of the solvent, the residue was purified on a silica gel column and eluted with petroleum ether/acetone to obtain DA (43 mg, 86% yield). The MS and 1 H NMR spectra were consistent with the literature data.
Preparation of licorice water extract (LWE)
Licorice drug materials (20 g) were ground into a crude powder, and boiled in 100 mL of water for 1 h twice. The decoctions were combined and concentrated to 10 mL in vacuum at 50°C. The resulting solution was used as LWE (equivalent to 2 g crude drug/mL) and was stored at -20°C. For LC/MS analysis, an aliquot of 0.1 mL of LWE was diluted into 1 mL with water, and then filtered through a 0.45 μ m membrane.
Animals
Male Sprague-Dawley rats (180-220 g) were obtained from the Laboratory Animal
Center of Peking University Health Science Center. The rats were housed in a cage (465×300×200 mm) in a breeding room at 25°C, 60±5% humidity and a 12 h dark-light cycle for 3 days, and were given access to water and normal chow ad libitum. All animals were fasted overnight before experiments. The animal facilities and protocols were approved by Animal Care and Use Committee of Peking University Health Science Center.
All procedures were in accordance with the National Institute of Health guidelines regarding the principles of animal care (2004).
Drug administration to rats
The pure compounds, including LG, LQ, LA, ILG, ILQ, ILA, ONO, DHF and IAA were suspended in 0.5% CMC-Na, and were given to rats (n=2) orally at 40 mg/kg separately. As an exception, GLY was dissolved in water and orally administered to rats (n=2) at 270 mg/kg. LWE was dosed to rats (n=2) at 20 g/kg (high dosage) and 0.9 g/kg (normal dosage, equivalent to 9 g crude drug/day for a 60 kg human), respectively.
Preparation of plasma samples
Blood was collected from the angular vein at 0.25, 0.5, 1, 2, 4, and 6 h, and was centrifuged at 4,000 rpm for 15 min, respectively. The plasma samples were mixed, and an aliquot of 3 mL was treated with four volumes of methanol-acetonitrile (2:1, v/v) to precipitate protein. After centrifuging at 9,500 rpm for 5 min, the supernatant was dried in vacuum at 37°C, dissolved in 300 μ L of methanol, and then filtered through a 0.45 μ m membrane.
Preparation of urine and feces samples
Rats were held in metabolism cages (DXL-D, Keke Medical Model Co. Ltd, Shanghai), and urine and feces samples were collected for 24 h. An aliquot of 2 mL of urine was loaded on a pre-treated SPE column (Oasis HLB 6 cc, Waters), washed with 3 mL of water, and then successively eluted with 3 mL of 5% methanol and 5 mL of methanol. The methanol eluate was collected and dried in vacuum at 37°C. The residue was was used as the collision gas and high purity nitrogen (N 2 ) as the nebulizing gas. The optimized parameters in the negative ion mode were as follows: ion spray voltage, 4.5 kV;
sheath gas (N 2 ), 50 arbitrary units; auxiliary gas (N 2 ), 10 units; capillary temperature, 
LC/qTOF-MS analysis
High-accuracy mass spectra were obtained on a 6510 qTOF mass spectrometer coupled to an Agilent 1200 series HPLC (Agilent, USA). The HPLC conditions were the same as those for HPLC/DAD/ESI-MS n analysis. The ESI source was operated in the negative ion mode. High-purity nitrogen (N 2 ) was used as both drying gas (10 L/min) and nebulizing gas (40 psig). 
Licorice compounds database (LCD)
To help deduce the origin of metabolites, a home-made information database of all compounds isolated from Glycyrrhiza species was established (LCD). The information was 
RESULTS
Characterization of in vivo metabolites of ten single licorice compounds in rats
Ten representative compounds of licorice were selected to identify their metabolites.
These compounds included three flavanones (LG, LQ, and LA), three chalcones (ILG, ILQ, and ILA), two isoflavones (ONO and IAA), one flavone (DHF), and one saponin (GLY).
They represent different structural types, and are also the major constituents of licorice ( Fig.   1 and Fig. 2 ). Their UV spectra, together with MS and MS/MS spectra are given as supplemental data (Supplemental Figure 2) . After oral administration, their metabolites in rat plasma, urine and feces were characterized by HPLC/DAD/ESI-MS n and LC/qTOF-MS (Table 1 ) (Supplemental Table 1 ). The following information for each metabolite was collected for structural elucidation: HPLC retention time, UV spectra from DAD detector, high-accuracy deprotonated molecule provided by qTOF-MS, and MS n fragment ions obtained from ion trap mass spectrometry. A total of 68 metabolites were characterized.
Among them, 13 were identified by comparing with reference standards, including the 10 administered licorice compounds, together with daidzein, davidigenin, and glycyrrhetinic acid. When pure standards were not available, the structures were partially characterized based on their spectral information. Glucuronide and sulfate conjugates produced
-fragments in the MS/MS spectra, respectively. For glucuronides, the [glucuronic acid-H] -ion at m/z 175 could also be observed (Holcapek et al., 2008) .
Structures of these conjugates were further confirmed by enzyme hydrolysis. After being treated with β-glucuronidase and sulfatase, the conjugates could be converted into their corresponding aglycones, most of which were then identified by comparing with reference 
Metabolites of flavanones
The metabolism of three licorice flavanones, LG (36), LQ (12), and LA (10) was studied. These compounds per se could be detected in plasma samples. In addition, a number of metabolites were characterized. The major reactions included glucuronidation, sulfation, hydrolysis, isomerization, and hydrogenation.
Glucuronidation was the major metabolic reaction for licorice flavanones. , 2010) . UV spectra were used to differentiate the isomers. Metabolites 11 and 13 showed an absorption maximum typical for flavanones at 270-280 nm, and were characterized as LG-O-GluAs. Metabolite 33 showed an absorption maximum typical for chalcones at 372 nm, and was characterized as ILG-O-GluA (Fig. 3) .
ILG-O-
The above conjugates were confirmed by enzyme hydrolysis. When the LG-plasma sample was treated with β -glucuronidase, peaks for metabolites 11, 13 and 33 disappeared, and peaks corresponding to LG and ILG increased remarkably (Fig. 3) . Thus, it could be This article has not been copyedited and formatted. The final version may differ from this version. LG or ILG. Shimamura et al. had isolated five LG glucuronide and sulfate conjugates from rat bile (Shimamura et al., 1993) , which was consistent with our results.
Flavanone glycosides could be converted into their aglycones by hydrolysis. When LA and LQ were given to rats, high amounts of LG were detected in both urine and feces (Table 1) . Isomerization into chalcones was also common for flavanones. ILA (24), ILQ (26), and ILG (46) were detected in rat plasma or urine samples when LA, LQ, and LG were administered, respectively. In addition, flavanones could be further metabolized into dihydrochalcones in urine. Several peaks in the LQ-urine sample were converted into davidigenin (4,2',4'-trihydroxydihydrochalcone, DA) after enzyme hydrolysis. The pure compound of davidigenin was chemically synthesized from isoliquiritigenin by Pd-C hydrogenation, and thus allowed the structural characterization. In accordance to our results, Homma et al. had also detected DA from human urine after administration of licorice (Homma et al., 1997) . The metabolic pathways of licorice flavanones are illustrated in Scheme 2.
Metabolites of chalcones
This article has not been copyedited and formatted. The final version may differ from this version. The metabolism of three licorice chalcones, ILG (46), ILQ (26) and ILA (24) was studied. Interestingly, majority of the chalcone metabolites were the same as the flavanones metabolites which we had described. These metabolites included glucuronide conjugates, sulfate conjugates, and glucuronide-sulfate conjugates. The results indicated that chalcones and flavanones could be converted to each other in rats, which was consistent with literature report (Cuendet et al., 2010 
Metabolites of IAA
IAA is an isoflavone bearing two isoprenyl groups (Fig. 2) . The parent compound (67) was detected in plasma, urine and feces samples. In addition, fourteen metabolites of IAA were detected, including two monoglucuronides (55 and 65), two diglucuronides (50 and 
Metabolites of DHF
DHF (27) was poorly absorbed into circulation after oral administration. DHF itself was detected in urine at a low concentration, and two glucuronides (5 and 8) were detected in plasma and urine at trace amounts (Supplemental Figure 4) . In contrast, DHF was abundant in feces, indicating it had poor bioavailability.
This article has not been copyedited and formatted. The final version may differ from this version. Metabolites of GLY GLY (48) was the most abundant saponin in LWE (Fig. 1) . When GLY was orally administered to rats, it was detected in both plasma and feces. GLY could lose one or two molecules of glucuronic acid to produce glycyrrhetinic acid-O-GluA (57 and 60) and glycyrrhetinic acid (68), respectively. In addition, a hydroxylated derivative of glycyrrhetinic acid (63) was observed in plasma. It might be hydroxylated at C-22α or C-24, according to the previous report on glycyrrhetinic acid metabolism (Gao et al., 2007) .
Glycyrrhetinic acid was the predominant metabolite, indicating that hydrolysis was the major metabolic reaction for GLY. A metabolic pathway of GLY is proposed (Supplemental Figure 5 ).
Characterization of more in vivo metabolites of LWE at a high dosage
In order to characterize more LWE metabolites other than those derived from the above ten compounds, a high dosage of LWE (20 g/kg) was given to rats. Plasma and urine samples were collected for HPLC/DAD/ESI-MS n and LC/qTOF-MS analysis. HPLC/UV chromatograms and LC/MS total ion currents of the dosed samples were compared with blank samples. Peaks that only appeared in dosed samples could be absorbed licorice constituents or metabolites. A total of 22 new licorice constituents or metabolites were characterized in this step (Table 2 ) (Supplemental Table 2 ).
Characterization of absorbed licorice constituents
In the LC/MS profile of LWE dosed plasma sample, two compounds (88 and 89)
Analysis of normal dosage bio-samples by LC/SRM-MS
In this step, a highly sensitive and selective LC/SRM-MS method was established.
The structures of metabolites characterized in the above two steps, as well as their MS/MS spectral data were used to set the ion pairs for selected reaction monitoring (SRM) detection. By using this LC/SRM-MS method, a total of 42 metabolites (including licorice constituents) in plasma and 62 in urine were detected after oral administration of LWE at a normal dosage of 0.9 g/kg (Supplemental Figure 6 ) (Supplemental Figure 7) . This article has not been copyedited and formatted. The final version may differ from this version. 
Discussion
The metabolic studies of TCMs have been challenging due to their complicated chemical composition and fairly low concentrations in bio-samples. In this study, we proposed a three-step strategy to fully profile the in vivo metabolites of TCMs. By using licorice as a model herb, we managed to characterize 90 licorice metabolites in rats, including 12 intact licorice compounds and 78 biotransformed metabolites. By using a highly sensitive LC/SRM-MS method, majority of these metabolites could be detected in rat plasma or urine after oral administration of normal clinical dosage of licorice water extract.
Considering the complicated chemical composition of licorice, we studied the metabolism of ten single licorice compounds individually as the first step of our strategy.
As only one single compound was fed to rats, the metabolic profiles were easy to be elucidated. The metabolites were characterized by a generally used procedure (Holcapek et al., 2008) . These ten compounds were abundant in licorice water extract, and might well produce the major in vivo metabolites of licorice. The final results proved that our assumption was correct. Among the 90 metabolites we detected, 68 (or 75%) were derived from these ten compounds. More importantly, these ten compounds belong to flavanone, chalcones, flavone, isoflavone, prenylated isoflavone, and saponin, respectively, and This study aimed to profile licorice metabolites at an oral clinical dosage (0.9 g/kg, according to Chinese Pharmacopoeia). At this low dose, most metabolites could not be detected by conventional HPLC/DAD/ESI-MS n due to their low concentrations. Therefore, in the third step of our strategy, we used a highly sensitive and selective LC/SRM-MS technique to detect the metabolites since tandem mass spectrometry using SRM has a lower limit of detection than scanning mass spectrometry (Supplemental Figure 8) . However, a prerequisite of this technique is that structures of possible metabolites should be known.
Fortunately, this knowledge had already been obtained in the first two steps of our strategy.
Most of the pre-characterized metabolites gave an obvious signal even though the matrix was very complicated and the concentrations were fairly low (Supplemental Figure 6) (Supplemental Figure 7) .
To mimic TCM clinical use, licorice was cooked in water to obtain the extract. The dosage was 0.9 g/kg in rats, equivalent to 9 g per day for human. Under these conditions, a total of 42 metabolites (including intact licorice compounds) were detected in rat plasma and 62 in urine by LC/SRM-MS. However, some metabolites discovered in steps one and two were not detected in step three, like licorice-saponin A3, licorice-saponin G2, and most IAA derivatives. Given the good sensitivity of SRM technique, it was unlikely these compounds could not be detected. Instead, we consider that single compound dosing or too and licorice-saponin G2. In the HPLC chromatogram of licorice water extract, these compounds were the major peaks (Fig. 1) . Thirteen of these 19 compounds had been reported to possess significant pharmacological activities (Supplemental Table 3 ). For instance, LQ and ILQ showed anti-depression activities in mice forced swimming test and tail suspension test, as well as in chronic variable stress induced depression rat model (Wang et al., 2008; Zhao et al., 2008) . LA, LQ and LG showed antitussive activities in capsaicin-induced cough model (Kamei et al., 2003) . Aside from these extensively studied compounds, less well-known licorice compounds also produced major metabolites. For example, three metabolites were derived from glycycoumarin, which was present in LWE at a noticeable amount. Glycycoumarin had been reported to show potent antispasmodic activities on carbamylcholine-induced mouse jejunum contraction (Sato et al., 2006) . A famous TCM formula Shaoyao-Gancao Decoction (composed of licorice and peony root) is widely used to treat spasm and abdominal pain (Katsura, 1995 
